StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Gross Profit by Quarter

Gross Profit ($M)

QuarterlyAnnual

Novartis Gross Profit: $11,421M in Q3 2026, up 5.6% from a year earlier.

Latest, Q3 2026
11,421
Period ended Sep 30, 2026
Change on a year earlier
+5.6%
10,819 in Q3 2025
History
30 quarters
Since Q2 2017
Sources
21
Documents cited below

Where the Q3 2026 figure comes from

“|| Gross profit | 11 421 | 10 819”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGross Profit ($M)Year on yearSource
Q3 2026Sep 30, 202611,421+5.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202611,241-2.4%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 202610,065-3.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202510,249+0.1%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202510,819+8.9%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202511,514+18.7%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 202510,393+15.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202410,234–Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20249,938–Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20249,699+15.4%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20249,024-2.7%Novartis Form 6-K (0001370368-25-000010) ↗
Q2 2023Jun 30, 20238,403-10.0%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2023Mar 31, 20239,277+3.6%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 20229,014-5.6%Novartis Form 6-K (0001370368-23-000008) ↗
Q3 2022Sep 30, 20229,036-4.2%Novartis Form 6-K (0001370368-22-000077) ↗
Q2 2022Jun 30, 20229,334-0.5%Novartis 6-K (0001370368-22-000059, filed 2022-07-19) ↗

Cite this data

StockData. (2026). Novartis Gross Profit ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-gross-profit

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.